Tweet

https://twitter.com/ajitsuryak/status/1365604476392931328

https://twitter.com/itstarh/status/1408808172517695493

This Thread may be Removed Anytime!

Twitter may remove this content at anytime! Save it as PDF for later use!

More from @sakir_saiyed_

Sakir saiyed

@sakir_saiyed_

28 Jun

#Praj thread

@ishmohit1

Praj is not just an Ethanol Play. Found this bit to be the best, creating mind map of optionalities requires in-depth understanding and use of knowledge from multiple domains... @ishmohit1 @soicfinance @unseenvalue 👌🏻🤟🏻💯

Unseen Trends in Biotechnology by Mr. Sajal Kapoor

Read 19 tweets

Sakir saiyed

@sakir_saiyed_

27 Jun

https://twitter.com/sakir_saiyed_/status/1409210082030538757

Pharma 🧬💊⭕️ thread

https://twitter.com/sakir_saiyed_/status/1409210082030538757

https://twitter.com/sakir_saiyed_/status/1406535421861847045

https://twitter.com/sakir_saiyed_/status/1406535421861847045

https://twitter.com/sakir_saiyed_/status/1409399765461180419

https://twitter.com/sakir_saiyed_/status/1409399765461180419

Read 5 tweets

Sakir saiyed

@sakir_saiyed_

26 Jun

#syngene 🧬

https://twitter.com/sakir_saiyed_/status/1408762195312214017

#2021 #annualreport

https://twitter.com/sakir_saiyed_/status/1408762195312214017

https://twitter.com/sakir_saiyed_/status/1408035414368083968

https://twitter.com/sakir_saiyed_/status/1408035414368083968

Read 5 tweets

Sakir saiyed

@sakir_saiyed_

26 Jun

#LaurusLab 🧬⭕️ thread

https://twitter.com/punitbansal14/status/1395255235438948358

https://twitter.com/punitbansal14/status/1395255235438948358

Read 15 tweets

Sakir saiyed

@sakir_saiyed_

26 Jun

https://twitter.com/sakir_saiyed_/status/1408757890156883974

#Syngene 🧬 Way Forward:

The year ahead offers positive prospects reflecting the strong fundamentals of the global biopharmaceutical industry against a backdrop of potential further disruption due to the second wave of the pandemic.

https://twitter.com/sakir_saiyed_/status/1408757890156883974

1. The extension of our strategic collaboration with Bristol Myers Squibb until 2030 will provide scope for new areas of R&D within that relationship.

2. We have initiated multiple expansion and capability-building initiatives. The phase-III expansion of the Hyderabad laboratory is ongoing and will offer capacity for an additional 300 scientists.

Read 7 tweets